) was a big mover last session, as the company saw its shares rise
nearly 18% on the day. The move came on solid volume too with far
more shares changing hands than in a normal session. This reverses
the recent trend for the company, as the stock is now down over 10%
in the past one-month time frame.
This medical instrument company saw one positive estimate revision
in the last 30 days. Its Zacks Consensus Estimate also moved higher
over the same period, implying more solid trading potential for
IMRIS. So make sure to keep an eye on this stock going forward to
see if yesterday's rally can turn into more strength down the road.
IMRIS currently has a Zacks Rank #2 (Buy) while its
Other stocks worth considering in the MedTech sector include
Natus Medical Inc.
). While Natus Medical holds a Zacks Rank #1 (Strong Buy),
AngioDynamics and CryoLife carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ANGIODYNAMICS (ANGO): Free Stock Analysis
NATUS MEDICAL (BABY): Free Stock Analysis
CRYOLIFE INC (CRY): Free Stock Analysis Report
IMRIS INC (IMRS): Free Stock Analysis Report
To read this article on Zacks.com click here.